MMV is seeking to fill the following posts to join our dedicated team:

Deadline: 14 November 2014


Join MMV and partners,
2-6 November in New Orleans,
for these various symposia and sessions.

New APPMG Report

Malaria in 2014:
An Unprecedented Opportunity
at the Dawn of a New Era

Partner interview

Masahiko Koike, Director, Pharmaceutical Technology R&D Laboratories, Takeda, explains how the company is contributing to two exciting antimalarial drug projects and what it’s like to work with MMV.

Latest science article

A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs


New treatment will contribute to WHO’s artemisinin resistance containment strategy

15 October 2014

Partner and staunch supporter of MMV, Dr Rogers will be sorely missed

09 September 2014
Dr Jörg Möhrle, Head of Translational Medicine, MMV

Conference provides a forum for experts to discuss Germany’s role in malaria and poverty-related diseases

01 July 2014

Tool Kit will help plan, implement and monitor WHO-recommended life-saving intervention for children

29 April 2014

An investigational medicine being developed for the treatment and relapse prevention of P. vivax

28 April 2014